• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Only Half Of S&P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards?
May 14, 2025
Tickers ALB ARE BDX BIIB
Tags Equities DOW Benzinga
From Benzinga
10 Worst Performing Large-Caps Last 12 Months
May 08, 2025
Tickers ALB BIIB CRL DOW
Tags MRNA CRL SMCI
From TalkMarkets
4 Stocks to Buy for a Potential “Summer Panic”
May 04, 2025
Tickers BIIB DLR O SABR
Tags Market Analysis SABR BIIB
From InvestorPlace
Biogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff Impact
May 01, 2025
Tickers BIIB ESALY NEWS
Tags Health Care BIIB Earnings
From Benzinga
10 Worst Performing Large-Caps Last 12 Months
May 01, 2025
Tickers ALB APA BIIB CRL
Tags MCHP SMCI EL
From TalkMarkets
Earnings Scheduled For May 1, 2025
May 01, 2025
Tickers AAMI AAPL ABNB ACCO
Tags Earnings FULC TEAM
From Benzinga
14 Analysts Have This To Say About Biogen
April 22, 2025
Tickers BIIB
Tags BZI/AAR BIIB Analyst Ratings
From Benzinga
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
April 16, 2025
Tickers ABBV AZN BIIB BMRN
Tags Benzinga AZN News
From Benzinga
Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion
April 16, 2025
Tickers BIIB ESALY LLY NEWS
Tags Health Care BIIB Stories That Matter
From Benzinga
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
April 04, 2025
Tickers ALNY AMGN BIIB GILD
Tags Biotech Market News GILD
From Benzinga
What 14 Analyst Ratings Have To Say About Biogen
April 04, 2025
Tickers BIIB
Tags Market News Benzinga BIIB
From Benzinga
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen
March 28, 2025
Tickers BIIB LLY NEWS
Tags Market News Biotech Top Stories
From Benzinga
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025
March 27, 2025
Tickers BIIB LLY
Tags Market News Recent Press Releases ESAI/Y
From Motley Fool
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
March 21, 2025
Tickers AMGN AZN BIIB BMY
Tags News AZN UCBJF
From Benzinga
Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy
March 19, 2025
Tickers BIIB NEWS NVS RHHBY
Tags Large Cap Briefs Benzinga
From Benzinga
How Is The Market Feeling About Biogen?
March 07, 2025
Tickers BIIB
Tags Market News BZI/SHORTHIST Short Sellers
From Benzinga
Alzheimer's Drugs From Eli Lilly And Biogen Still Deemed Too Costly For NHS Funding
March 06, 2025
Tickers BIIB LLY NEWS
Tags Government BIIB Stories That Matter
From Benzinga
NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
February 24, 2025
Tickers BIIB NEWS NVS SDZNY
Tags General Topics BIIB
From Benzinga
Biogen Strengthens Pipeline With Stoke Therapeutic's Dravet Syndrome Candidate Via Multi-Million Dollar Deal
February 18, 2025
Tickers BIIB NEWS STOK
Tags BIIB Stories That Matter Biotech
From Benzinga
Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts
February 13, 2025
Tickers BIIB NEWS
Tags Benzinga News Large Cap
From Benzinga
Biogen Analysts Lower Their Forecasts After Q4 Results
February 13, 2025
Tickers BIIB NEWS
Tags Market News Trading Ideas Markets
From Benzinga
Forecasting The Future: 10 Analyst Projections For Biogen
February 13, 2025
Tickers BIIB
Tags Analyst Ratings BZI/AAR BIIB
From Benzinga
Biogen Delivers Q4 Beat, Analyst Focuses On Leqembi Expansion, 2025 Outlook
February 12, 2025
Tickers BIIB NEWS
Tags Market News Biotech Top Stories
From Benzinga
Biogen (BIIB) Q4 2024 Earnings Call Transcript
February 12, 2025
Tickers BIIB
Tags BIIB Recent Press Releases Market News
From Motley Fool
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
February 12, 2025
Tickers AIG ALKS AMX AVXL
Tags DBD Equities Z
From Benzinga
Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma
February 12, 2025
Tickers BIIB NEWS RPRX
Tags Stories That Matter BIIB Earnings
From Benzinga
US Stocks Set For A Cautious Start Ahead Of Inflation Data: Expert Says 'Strong Bull Markets Tend To Roar Back To Life After Corrections'
February 12, 2025
Tickers ASIA BIIB CME CPI
Tags CPI Bonds QQQ
From Benzinga
Earnings Scheduled For February 12, 2025
February 12, 2025
Tickers ACRE ADN AEIS AEMD
Tags BZI/UE GNRC WCN
From Benzinga
Biogen Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 12, 2025
Tickers BIIB NEWS
Tags Analyst Ratings Expert Ideas BIIB
From Benzinga
What To Expect From Alzheimer's Drugmaker Biogen's Q4 Earnings On Wednesday?
February 11, 2025
Tickers BIIB NEWS SAGE
Tags Benzinga News Briefs
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap